Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
UKALL R2 - Acute Lymphoblastic Leukaemia trial
ISRCTN ISRCTN95257778
DOI 10.1186/ISRCTN95257778
ClinicalTrials.gov identifier
EudraCT number
Public title UKALL R2 - Acute Lymphoblastic Leukaemia trial
Scientific title
Acronym UKALL R2
Serial number at source G8223452
Study hypothesis To compare continuing chemotherapy with unrelated donor BMT in relapsed childhood ALL following a common re-induction and consolidation regimen.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Acute Lymphoblastic Leukaemia
Participants - inclusion criteria They are children under 15 years at original diagnosis and treated on UKALL trials or pilot studies with first relapse less than 4 years from the start of treatment of ALL at any site and no suitable related bone marrow treatment (BMT) donor is available
Participants - exclusion criteria 1. They are multiply relapsed patients
2. They have a prior history of toxicity or organ damage such that completion of the protocol is felt unlikely at the outset
3. They have had an isolated CNS or testicular relapse more than 6 months off treatment.
Anticipated start date 01/02/1995
Anticipated end date 30/09/2008
Status of trial Completed
Patient information material
Target number of participants 200 - Closed to recruitment - in long term follow-up
Interventions Continuing chemotherapy/unrelated donor BMT
Primary outcome measure(s) Survival, disease free survival
Secondary outcome measure(s) Not provided at time of registration
Sources of funding UK Medical Research Council
Trial website
Publications Results on http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15982346
Contact name Dr  PJ  Darbyshire
  Address The Children's Hospital
Ladywood Middleway
  City/town Birmingham
  Zip/Postcode B16 8ET
  Country United Kingdom
  Email
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 06/04/2000
Last edited 04/10/2007
Date ISRCTN assigned 06/04/2000
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.